Global Over the Counter and Direct to Consumer Infectious Disease Diagnostics Market Forecasts to 2024
Dublin, June 29, 2021 (GLOBE NEWSWIRE) -- The "OTC/DTC Infectious Disease Diagnostics - Strategies and Trends. COVID-19 Adjusted Forecasts by Application by Channel by Country. With Market Analysis, Executive Guides, Customization and COVID-19 Market Opportunity Analysis. 2020 to 2024" report has been added to ResearchAndMarkets.com's offering.
Over the Counter and Direct to Consumer diagnostics set to help solve the pandemic problem. New technologies create rapid test solutions for the home market. Self-Sampling technology key.
Genetic DTC testing led the way. Now infectious disease testing is moving directly to the consumer. New sampling technology, rapid and multiplex tests have changed the picture on how and where testing is done. And the COVID-19 situation will lead the charge. This report explores the DTC outlook for different syndromes. Find out where the action is and the learn about the players.
Exciting technical developments especially in the seesaw between PCR and immunoassay, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication. Even CRISPR diagnostics are now coming into play.
The report has hundreds of pages of information including a complete list of Current 2019 United States Medicare Fee Payment Schedules to help sharpen your pricing.
The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.
Key Topics Covered:
i. Market Guides
iA. Situation Analysis and COVID-19 Market Analysis
iB. Guide for Executives and Marketing Staff
iC. Guide for Investment Analysts and Management Consultants
1. Introduction and Market Definition
2. The Infectious Diseases - Guide to the Pathogens
3. Industry Overview
4. Market Trends
5. OTC/DTC Infectious Disease Testing Recent Developments
Recent Developments - Importance and How to Use This Section
Importance of These Developments
How to Use This Section
FemtoDx Launches Rapid At-Home Test Development for COVID-19
FDA approves first at-home coronavirus test
Free Home HIV Tests Detect More Infections
Biohacking trend supports self testing.
PerkinElmer and EverlyWell to Expand U.S. At-Home Health Test Market
Mylan, Atomo Diagnostics Get WHO Prequalification Approval for HIV Self-Test
Miraca Holdings Inc. and Seventh Sense Biosystems, Inc. Announce Distribution Agreement
OraSure Technologies, Inc. Announces Two Acquisitions
Mylan signs HIV test commercialisation deal with Atomo Diagnostics
Nigerian Govt Approves Alere HIV Self-Test Kit
Rapid HIV tests vary in their accuracy
Montreal researchers develop HIV self-testing app
Boots launches UTI test and treat service across 37 branches
Scanwell Health moves beyond home UTI testing with nationwide kidney disease study partnership
Healthy.io raises $18 million for at-home urinalysis tests
LetsGetChecked collects $30M more for at-home health testing
TestCard, a $4 Urine Test Read by Smartphone
Digital Health Startup EverlyWell Raises $50M
Thriva adds test-at-home kits for female hormone and cortisol stress
Tasso scores $6.1M for patch-based home blood testing
LabCorp to offer self-testing home kits.
1Drop Diagnostics draws $4.25M for portable blood diagnostic panel
DBS Systems HEMAXIS receives CE/IVD mark 211 myLAB Box Announces $1.56M in Seed Funding
Abbott HbA1c point-of-care test reliably diagnoses diabetes
6. Profiles of Key Diagnostic Testing Companies
7. Global Market Size
8. Global Market by Syndrome
9. Global Market by Channel
Appendices
Companies Mentioned
1DropDiagnostics
Abbott Diagnostics (Alere)
Ador Diagnostics
Akkoni Biosystems
Alveo Technologies
Applied BioCode
Atlas Genetics
Atomo Diagnostics
Aus Diagnostics
BD Diagnostics
Bio-Rad Laboratories
Biocartis
BioFire Diagnostics
bioMerieux
Bosch Healthcare Solutions GmbH
Cepheid
Curetis
DBS Systems
Diagenode Diagnostics
Diasorin
Everlywell
Fusion Genomics
GenePOC Diagnostics
GenMark Dx
Healthy.IO
Hologic
Inflammatix
Inui Health
Invetech
Janssen Diagnostics
Karius
Labcorp - Pixel
Letsgetchecked
Lexigene
Luminex
Mbio Diagnostics
Mesa Biotech
Mobidiag
myLabBox
Mylan
Nanomix
Orasure
Oxford Nanopore
Panagene
Primerdesign
Prominex
Qiagen (Statdx)
Quantumdx
Quest Diagnostics - Quest Direct
Roche Molecular Diagnostics
Scanwell Health
Seegene
Sensovation
Seventh Sense Biosystems.
Siemens Healthineers (Fast Track Diagnostics)
SkylineDx
T2 Biosystems
TestCard Diagnostics
Thermo Fisher
Thriva
Veramarx
XCR Diagnostics
For more information about this report visit https://www.researchandmarkets.com/r/jmo0h6
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900